1,3-DMAA
weak data4 sources
A sharp, effective stimulant that does exactly what a stimulant does: jack up your sympathetic nervous system, spike your energy, and temporarily kill appetite. The problem is the cardiovascular price tag. People have died on it, cardiac arrests during exertion in multi-ingredient stacks, and the FDA pulled it for good reason. The incretins make it obsolete for fat loss. If you want a stim pre-workout, caffeine is boring but alive.
What it is
A synthetic sympathomimetic amine, structurally close enough to amphetamine that your dopamine transporter and noradrenaline stores cannot tell the difference. It works indirectly: it kicks noradrenaline loose and blocks dopamine reuptake, which is why the energy is real but the crash and the cardiovascular hit come with it. The “geranium extract” marketing was a fiction, tested and debunked.
On the weight-loss shelf 1,3-DMAA belongs to the old stimulant school: burn more, eat less, push harder, absorb the side effects. That model works for a few weeks and costs the cardiovascular system the whole time. After the FDA removed it from the market, the supplement industry shifted to its positional isomer 1,4-DMAA to dodge the ban. Meanwhile retatrutide, tirzepatide, and semaglutide broke the stim model entirely by solving appetite without the sympathetic ride, and there is no reason to go back.
What the research shows
The pharmacology is mapped in humans. The efficacy for anything useful is not:
Realistic protocols
I am not recommending 1,3-DMAA for fat loss. The incretins do the appetite job better, safer, and without the cardiovascular roulette. If you already have it and intend to use it as a pre-workout stimulant, here is what the community ran and what the pharmacology says about it.
The standard pre-workout dose was 25 to 50 mg, swallowed 30 to 45 minutes before training. Most products paired it with caffeine, which amplifies the blood-pressure spike. Higher doses circulated, 75 mg was common in the old labels, but the hemodynamic cost scales with dose and the benefit plateaus. 1,3-DMAA lingers long enough that a second dose in the same day stacks blood levels in a way shorter stims do not, so one dose was the rule. Never combine it with other sympathomimetics, and never run it under heavy cardiovascular stress in heat. That is the exact scenario in the fatal case reports.
Side effects
The side profile is the sympathomimetic profile, dose-dependent and predictable: